You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 244 No. 20, November 21, 1980 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Chronic Obstructive Pulmonary Disease With Orally Administered Theophylline

A Double-Blind, Controlled Study

Michael R. Alexander, MSc; William L. Dull, MD; John E. Kasik, MD, PhD

JAMA. 1980;244(20):2286-2290.


Abstract

Theophylline is commonly prescribed for chronic obstructive pulmonary disease (COPD), although controlled studies do not exist to support this use. We administered theophylline and placebo orally to 40 ambulatory COPD patients in a double-blind, crossover manner. Pulmonary function tests were conducted before and after isoproterenol nebulization on the final day of each four-week study period. Theophylline therapy produced small, but significant, increases over placebo in mean values. However, only the forced expiratory volume in 1 s was "improved," according to published criteria. There were no significant differences in subjective effects between treatment periods. Six patients were identified as "responders"; responder status could be predicted on the basis of improvement in flow rates after isoproterenol nebulization. Theophylline therapy is not beneficial to most COPD patients, and potential responders should be given carefully monitored therapeutic trials rather than arbitrarily being given maintenance therapy.

(JAMA 244:2286-2290, 1980)



Author Affiliations

From the Departments of Pharmacy (Mr Alexander), and Medicine (Drs Dull and Kasik), Veterans Administration Medical Center and Colleges of Pharmacy (Mr Alexander), and Medicine (Drs Dull and Kasik), University of Iowa, Iowa City.


Footnotes

Reprint requests to Pharmacy Department, Veterans Administration Medical Center, Iowa City, IA 52240 (Mr Alexander).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Theophylline for Irreversible Chronic Airflow Limitation: A Randomized Study Comparing n of 1 Trials to Standard Practice
Mahon et al.
Chest 1999;115:38-48.
ABSTRACT | FULL TEXT  

The Use of Theophylline in 'Irreversible' Chronic Obstructive Pulmonary Disease: An Update
Hill
Arch Intern Med 1988;148:2579-2584.
ABSTRACT  

Acute Response to Bronchodilator: An Imperfect Guide for Bronchodilator Therapy in Chronic Airflow Limitation
Guyatt et al.
Arch Intern Med 1988;148:1949-1952.
ABSTRACT  

Theophylline in Stable Chronic Airflow Obstruction: A Reappraisal
Dull and Alexander
Arch Intern Med 1984;144:2399-2401.
ABSTRACT  

Oral Theophylline Intoxication: A Serious Error of Patient and Physician Understanding
Mountain and Neff
Arch Intern Med 1984;144:724-727.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.